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Apoptosis: A new twist to the tale?
Emma Warbrick
The DNA helicases XPB and XPD, components of
transcription factor TFIIH, have been implicated in a
p53-induced apoptotic pathway. These new findings
suggest a role for the core TFIIH complex in the
coordination, not only of transcription, the cell cycle
and DNA repair, but also of apoptosis.
Address: Department of Anatomy and Physiology, Medical Sciences
Institute, University of Dundee, Dundee DD1 4HN, Scotland, UK.
Current Biology 1996, Vol 6 No 9:1057–1059
© Current Biology Ltd ISSN 0960-9822
The p53 protein is best known as the product of a tumour
suppressor gene, but it also plays a pivotal role in the coor-
dination of adaptive cellular responses to stress, whether
due to hypoxia, metabolic disarray or DNA damage. The
activation or expression of wild-type p53 in many types of
cell results in cell-cycle arrest. Other types of cell,
however, undergo rapid apoptotic death following the
expression of wild-type p53, and there is currently intense
interest in how cells choose between these two fates.
These observations are not simply an artefact of in vitro
cell culture systems, as in whole animals the induction of
p53 protein expression and its downstream consequences
are tightly regulated in distinct and tissue-specific manner
[1]. Understanding these processes is of considerable prac-
tical importance, given the important role of p53 pathways
in determining susceptibility to the effects of cancer radio-
therapy and chemotherapy.
How does p53 activate the apoptotic pathway? p53 is a
nuclear phosphoprotein and a transcription factor capable
of activating or repressing transcription of a wide range of
target genes. It appears, however, that transcriptional reg-
ulation is only one way in which p53 can regulate growth
arrest and apoptosis: several independent studies have
shown that some p53 activity distinct from transcriptional
activation in important for apoptosis [2–5]. Controver-
sially, Attardi et al. [6] find no evidence for transcription-
independent mechanisms of p53-mediated apoptosis and
suggest that the interpretation of previous studies may be
compromised by the presence of wild-type p53 in the cell
lines used.
Intriguing new results from Wang et al. [7] implicate the
XPB and XPD helicases as components of a p53-mediated
apoptotic pathway. These proteins, products of two of the
xeroderma pigmentosum (XP) genes, are well known for
their role in nucleotide excision–repair, but they are also
components of the basal transcription factor TFIIH,
required for the initiation of transcription, though not for
elongation, by RNA polymerase II. A ‘core’ TFIIH
complex consisting of at least five polypeptides has been
identified (Table 1). This core may not exist in vivo as a
functionally discrete entity, but may represent a particu-
larly stable complex of polypeptides which remain associ-
ated through fractionation steps in vitro. This core TFIIH
complex participates in various functions within the cell,
according to its interacting partners (Fig. 1).
Table 1
The constituent subunits of human ‘core’ TFIIH
TFIIH component Alternative names Proposed function
(yeast gene)
p89 (RAD25/SSL2) XPB, ERCC3 3′–5′ DNA helicase
p80 (RAD3) XPD, ERCC2 5′–3′ DNA helicase
p62 (TFB1)
p44 (SSL1) Zinc finger (DNA binding?)
p34 Zinc finger (DNA binding?)
Figure 1
TFIIH and its partners. This diagram shows a subset of the regulatory
interactions known to involve TFIIH. The core TFIIH complex is
essential for the initiation of transcription, and is associated in this
process with the CAK ternary complex; CAK is also required for the
activity of Cdks which regulate cell-cycle progression. TFIIH is also an
essential component of the nucleotide excision–repair (NER)
machinery; DNA repair must be coordinated with DNA replication for
the cell to maintain viability. p53-dependent transcriptional
transactivation — which requires TFIIH — induces cell-cycle arrest or
apoptosis. As discussed in the text, Wang et al. [7] have recently
reported evidence that p53 interacts with TFIIH to induce apoptosis
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DNA repair
p53
In its transcriptional role, TFIIH has an associated kinase
activity that phosphorylates the carboxy-terminal domain
of the largest subunit of RNA polymerase II. This phos-
phorylation is key step in the initiation of transcription in
vivo, through its precise role has not yet been elucidated.
The kinase activity resides in a ternary complex of MAT1,
cyclin H and the cyclin-dependent kinase (Cdk) Cdk4.
This ternary complex is also known Cdk-activating kinase
(CAK), in which guise it is responsible for the threonine
phosphorylation that is essential for Cdk activity. The
observation that the same kinase complex is involved in
the regulation of both transcription and the cell cycle is
evidence of their co-regulation. In contrast, when TFIIH is
involved in nucleotide excision–repair, it is not associated
with this kinase complex, but instead forms part of a multi-
protein complex — a ‘repairosome’ — with the other com-
ponents of the nucleotide excision–repair pathway (Fig. 1).
A new twist to the TFIIH tale has emerged with the
discovery that TFIIH and p53 interact via a series of mul-
tiple protein–protein contacts (Fig. 2). The acidic tran-
scriptional activation domains of both p53 and the viral
protein VP16 bind the p62 component of TFIIH [8,9]. A
carboxy-terminal region of p53 binds to XPB and XPD
and this region of p53 inhibits their DNA helicase
activities [7,8,10].
In its capacity as a transcriptional regulator, it is possibly
not surprising that p53 interacts with the components of
the transcriptional machinery. p53 is known to bind TBP-
associated factors (TAFs), which are components of the
transcription factor TFIID that interact with the TATA-
box binding protein (TBP). It is also known to interact
with several helicases — p53 was in fact first identified
through its interaction with the helicase SV40 large T
antigen, and it has since been found also to interact with
Rad3 (the yeast XPD homologue) and with CSB
(ERCC6), a helicase involved in transcription-coupled
nucleotide excision–repair [10]. Reassuringly, the recent
observation that p53-mediated apoptosis is significantly
reduced, though not abolished, in XPB and XPD mutant
fibroblasts suggests that the postulated interaction between
p53 and XPB/XPD occurs in vivo and is functionally impor-
tant [7]. This effect is specifically dependent on the pres-
ence of wild-type XPB/XPD proteins, and does not appear
to be due to a global defect in nucleotide excision–repair.
The implication is that XPB and XPD are components of a
p53-mediated apoptotic pathway. 
Is this form of apoptotic signalling dependent on the acti-
vation of transcription by p53? Experiments with mutant
forms of human p53 showed that their apoptotic activity
did not correlate with their ability to activate transcription
[7]. Interestingly, loss of the carboxy-terminal 50 amino
acids of p53 significantly reduced its apoptotic activity
without the loss of ability to activate transcription [7]. A
p53-derived carboxy-terminal peptide that includes the
proposed XPB/XPD-interaction domain can induce apop-
tosis upon microinjection [7]. These results suggest that
p53 can interact directly with XPB and XPD to induce
apoptosis independently of sequence-specific transcrip-
tional activation. In a parallel series of experiments, Haupt
et al. [2] found that the amino-terminal 214 amino acids of
murine p53, which lacks the ability to activate transcrip-
tion, can trigger apoptosis in HeLa cells. The differences
between these results and those of Wang et al. [7] may
reflect differences in the experimental systems, which
include the cell lines used, the state of the endogenous
p53 protein — which is inactivated by binding to the
human papillomavirus (HPV) E6 protein in HeLa cells —
and the species of origin of the artificially expressed p53.
How could the interaction of p53 with the XPB and XPD
helicases act to signal apoptosis? The inhibition of XPB
and XPD helicase activity by p53 in vitro suggests to the
naive observer that p53 would act in the cell to inhibit
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Figure 2
The interaction of p53 with components of the
core TFIIH complex. In some cases, the
results may appear contradictory, but it
appears that the amino terminus of p53
interacts with the p62 component of TFIIH,
while the carboxyl terminus interacts with XPB
and XPD. As discussed in the text, the latter
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DNA repair and/or transcription. Although the effect of
p53 activity upon rates of DNA repair is a highly contro-
versial topic, one can conceive of a situation in which the
p53–XPB/XPD interaction downregulates repair so that
DNA lesions persist and are sensed by the cell, which
takes them as a signal to undergo apoptosis. If this were
so, then all cells with DNA-repair defects would be
expected to undergo abnormally high levels of apoptosis
irrespective of p53 activation, which does not appear to be
the case.
A second possibility is that high levels of p53  downregu-
late the transcriptional activity of TFIIH. The results of
Wang et al. [7] indicate that the effects of mutations in
XPG and XPD on p53-mediated apoptosis are unlikely to
be due to a global TFIIH defect, although it is possible
that certain promoters are affected differentially [7]. An
alternative model has been proposed in which TFIIH
binds to RNA polymerase II stalled at a site of DNA
damage, and participates with the rest of the nucleotide
excision–repair machinery to repair the lesion. The binding
of p53 to components of TFIIH might activate p53, which
would then result in a delay in cell-cycle progression or
apoptosis. However, this is at odds with the observation
that TFIIH acts in the initiation of transcription rather than
the elongation step.
In summary, it appears that a core TFIIH complex is
involved in coordinating basal transcription, nucleotide
excision–repair and possibly also — via its association with
CAK — cell-cycle control. Recently published results
suggest that TFIIH also plays a role in regulating p53-
mediated apoptosis, though the precise mechanism and
the downstream effectors of this pathway remain to be
investigated. Perhaps CAK phosphorylates p53 bound to
damaged DNA and thus affects its activity. An attractive
model has core TFIIH not only coordinating repair and
transcription, but also integrating these processes into the
cell cycle and acting in concert with p53 to signal apoptosis
when cell damage is perceived as unrepairable.
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